Renaissance Group LLC Abbott Laboratories Transaction History

Renaissance Group LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $26.8 Million - $29.6 Million	-244,638 Reduced 98.72%	3,161 $359,000
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $375,010 - $459,043	-4,158 Reduced 1.65%	247,799 $27.3 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $462,938 - $555,448	4,846 Added 1.96%	251,957 $24.4 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $3.4 Million - $3.79 Million	33,736 Added 15.81%	247,111 $26.9 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $919,879 - $1.08 Million	-9,497 Reduced 4.26%	213,375 $21.6 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $957,064 - $1.12 Million	-10,068 Reduced 4.32%	222,872 $24.5 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $2.99 Million - $3.46 Million	30,915 Added 15.3%	232,940 $22.5 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $2.18 Million - $2.64 Million	-21,370 Reduced 9.57%	202,025 $22 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $408,989 - $498,736	-3,587 Reduced 1.58%	223,395 $26.4 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $454,610 - $556,645	-3,935 Reduced 1.7%	226,982 $31.9 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $3.73 Million - $4.13 Million	31,966 Added 16.07%	230,917 $27.3 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $3.2 Million - $3.76 Million	-30,227 Reduced 13.19%	198,951 $23.1 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $24.9 Million - $29.4 Million	229,178 New	229,178 $27.5 Million

3,336

1.36B

10M

9.48M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Group LLC with notifications on news.